MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.

Completed · Phase 4 · Has a placebo group

Conditions studied: Rosacea

In brief

The main objective of this study is to evaluate the efficacy of Ivermectin 1% cream (IVM) associated with Brimonidine 0.33% gel (Br) compared with the association of their respective vehicles in the treatment of moderate to severe rosacea.

Key facts

Study ID

NCT02616250

Run by

Galderma R&D

People needed

190

Starts

2015-12-01

Expected to finish

2016-09-01

Last updated by the study team

2021-02-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Fort Smith, Arkansas, United States
• Study site — Rogers, Arkansas, United States
• Study site — Sacramento, California, United States
• Study site — Orlando, Florida, United States
• Study site — Omaha, Nebraska, United States
• Study site — New York, New York, United States
• Study site — Pflugerville, Texas, United States
• Study site — Surrey, British Columbia, Canada
• Study site — Markham, Ontario, Canada
• Study site — Peterborough, Ontario, Canada
• Study site — Richmond Hill, Ontario, Canada
• Study site — Waterloo, Ontario, Canada
• Study site — Windsor, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.